54235

💉 CPT 54235 — Injection Of Corpora Cavernosa With Pharmacologic Agent(s) (eg, Papaverine, Phentolamine)

Quick Reference

wRVU: 1.30 | Global Period: 000 (same day) | Assistant Payable: ❌ No | Bilateral Indicator: 0

---

📋 Clinical Description

CPT 54235 describes the percutaneous injection of one or more pharmacologic (vasoactive) agents directly into the corpora cavernosa of the penis. A needle is inserted through the penile skin into the erectile tissue, and the agent is injected to produce hemodynamic changes within the corpora. The parenthetical examples in the descriptor — papaverine and phentolamine — are illustrative, not exhaustive; prostaglandin E1 (alprostadil), trimix (papaverine + phentolamine + alprostadil), bimix (papaverine + phentolamine), and phenylephrine are all captured under this same code. Technique does not change code selection; only the anatomic site (corpora cavernosa) and the injection act itself define the service.

N52.x erectile dysfunction is the most common indication, covering organic, vasculogenic, neurogenic, and post-procedural subtypes. Intracavernosal injection (ICI) therapy is used both diagnostically — to evaluate penile hemodynamics in conjunction with penile duplex Doppler ultrasound (93980) — and therapeutically, as a treatment for ED in patients who have failed or cannot tolerate phosphodiesterase-5 inhibitors. A secondary but important clinical application is the treatment of ischemic priapism (N48.3x) via injection of a sympathomimetic agent (phenylephrine) to achieve corporal detumescence; the same CPT code applies regardless of whether the intent is to induce or terminate an erection.

This procedure may be performed in the following clinical contexts:

• Diagnostic ICI with penile duplex Doppler ultrasound — Vasoactive agent (commonly alprostadil or trimix) is injected to induce a pharmacologic erection, after which 93980 duplex scan is performed to characterize arterial inflow and venous outflow; the injection is separately reportable from the ultrasound component.
• Therapeutic ICI for organic erectile dysfunction — In-office injection of trimix, bimix, or prostaglandin E1 in a patient with vasculogenic, neurogenic (N52.1), or post-prostatectomy (N52.31) ED who is being evaluated for self-injection therapy; the first office injection is performed by the provider to confirm dose, response, and technique before the patient is trained for home self-injection.
• Dose titration visit for ongoing ICI therapy — Follow-up office visit where the provider adjusts the ICI formulation dose and re-injects to confirm therapeutic efficacy; 54235 is billable at each titration visit performed by the provider; self-injections performed by the patient at home are NOT separately billable under 54235.
• Treatment of ischemic priapism in the office or emergency department — Corporal injection of phenylephrine (a pure alpha-agonist) to produce sympathomimetic vasoconstriction and detumescence; often performed in conjunction with 54220 (corporal aspiration/irrigation); when both aspiration and sympathomimetic injection are performed for priapism, 54235 may be reported alongside 54220, though many payers will only reimburse one code — verify payer policy.
• Post-priapism or post-pelvic-surgery erectile rehabilitation — ICI used as part of a penile rehabilitation protocol after 51597 (pelvic exenteration) or 52601 (TURP), where regular pharmacologic erections are intended to preserve penile smooth muscle oxygenation during recovery.

---

🔬 Anatomical & Procedural Considerations

Agent / Clinical Use	Mechanism	Key Coding & Clinical Notes
Papaverine (monotherapy)	Non-selective phosphodiesterase inhibitor; smooth muscle relaxation → arterial inflow increase and venous trapping	Least expensive agent; higher priapism risk than alprostadil; use alone or in bimix/trimix; all captured under 54235 regardless of agent
Phentolamine (in bimix/trimix)	Alpha-adrenergic blocker; potentiates smooth muscle relaxation; rarely used as sole agent	Never used alone clinically; always in combination; combination products (trimix, bimix) are still reported with single 54235 code
Alprostadil / Prostaglandin E1	Stimulates adenylyl cyclase → cAMP-mediated smooth muscle relaxation; also used as MUSE intraurethral pellet (different CPT)	Most commonly used single agent in U.S.; brand names Caverject, Edex; if physician supplies the drug, separately bill HCPCS J0270 (alprostadil) or J3490/J3590 (trimix) per AMA CPT Assistant guidance
Phenylephrine (for priapism reversal)	Alpha-1 adrenergic agonist; corporal smooth muscle contraction → detumescence	First-line pharmacologic treatment for ischemic priapism per AUA guidelines; same 54235 code applies even though clinical goal is opposite (terminating rather than producing an erection)
Trimix (papaverine + phentolamine + alprostadil)	Combined mechanism; highest efficacy for severe ED; compounded formulation	No commercially standardized product; compounded by specialty pharmacy; provider-supplied trimix is separately billable via HCPCS J3490 (NOC drug) or J3590; patient-supplied trimix is not additionally billable

Clinical Pearl

The AMA CPT Assistant (September 1996) explicitly states that the drug supply is NOT included in the payment for CPT 54235 — the code captures only the injection procedure itself. When the practice supplies the pharmacologic agent, separately report the corresponding HCPCS drug code (e.g., J0270 for alprostadil per 1 mcg, or J3490/J3590 for compounded trimix as a “not otherwise classified” drug). When the patient obtains the drug via prescription from an outside pharmacy and brings it to the office, there is no separately billable drug component for the practice. Failure to capture the separately billable drug supply when the practice is providing it is a common source of uncaptured revenue in urology offices.

---

✅ Procedure Includes

• Pre-injection assessment of the penis and identification of injection site
• Skin preparation and antiseptic application at the injection site
• Placement of needle into the lateral aspect of the corpora cavernosa, typically at the base or mid-shaft
• Injection of the pharmacologic agent(s) into the corporal body
• Manual compression of the injection site following needle withdrawal
• Monitoring for initial response (erection onset timing, rigidity, duration)
• Monitoring for immediate complications (excessive erection, hematoma, vasovagal response)
• Documentation of agent(s) used, dose administered, patient response, and any adverse events

---

❌ Excludes / Do Not Report Together

Code	Description	Relationship to 54235
54220	Irrigation of corpora cavernosa for priapism	Not bundled per NCCI — both may be reported in the same priapism treatment session (aspiration/irrigation with 54220 plus sympathomimetic injection with 54235); however, many payers will deny 54235 when reported alongside 54220 — verify payer-specific policy before billing both; document each service as distinct in the procedure note
93980	Duplex scan of arterial inflow and venous outflow of penile vessels; complete study	Not bundled per NCCI — 93980 is separately reportable when a penile duplex Doppler ultrasound is performed following a diagnostic ICI; 54235 provides the pharmacologic erection and 93980 captures the vascular imaging; append -59 to the lower-valued code to document distinct services if bundling edits are triggered
93981	Duplex scan of penile vessels; follow-up or limited study	Same as 93980 — separately reportable alongside 54235 when a limited/follow-up duplex scan is performed; confirm with payer
E/M codes (992xx)	Office visit, any level	Separately reportable only when modifier -25 is appended to the E/M code; the decision to perform the minor injection procedure is included in the 000-day global package; however, a separately documented and medically necessary E/M service (e.g., dosage counseling, management of a comorbidity) supports -25; note that several Medicare carriers have limited 54235 to once per beneficiary lifetime — if a -25 E/M is submitted at the same encounter, ensure the E/M addresses a distinct clinical issue beyond routine ICI management
Drug supply codes (J-codes)	HCPCS J0270 (alprostadil), J3490, J3590	NOT included in 54235 payment per AMA CPT Assistant — separately billable when the practice supplies the drug; do not separately report drug when the patient brings a prescription from an outside pharmacy

Bundling Alert — Global Period is 000, Not 010 or 090

CPT 54235 has a 000-day global period (same-day only). Follow-up visits on any subsequent date are not restricted by the global period and may be billed without a modifier. There is no 10-day or 90-day follow-up window to track. However, the single most significant payer restriction for this code is not the global period — it is frequency limitations. Several Medicare Administrative Contractors and commercial payers have historically limited 54235 to once per beneficiary lifetime or have specific visit-per-year caps. Always verify the applicable MAC’s or commercial payer’s coverage policy and frequency guidelines before billing multiple encounters with 54235, particularly for Medicare beneficiaries.

---

🌳 Code Tree — Surgery: Male Genital System — Introduction / Other Procedures on the Penis

54200-54300  Surgery: Male Genital System — Introduction and Other Procedures on the Penis
│
├── 54200   Injection procedure for Peyronie's disease  (Global: 010)
├── 54205   Injection procedure for Peyronie's disease, with surgical exposure of plaque  (Global: 090)
│
├── 54220   Irrigation of corpora cavernosa for priapism  (Global: 000)
│
├── ▶▶ 54235 ◀◀  Injection of corpora cavernosa with pharmacologic agent(s)  ← YOU ARE HERE  (Global: 000)
│
├── 54240   Penile plethysmography  (Global: 000)
├── 54250   Nocturnal penile tumescence and/or rigidity test  (Global: 000)
│
└── 54300-54440  Repair / Reconstruction / Implant Procedures on the Penis
    ├── 54400   Insertion of penile prosthesis; non-inflatable (semi-rigid)  (Global: 090)
    ├── 54401   Insertion of penile prosthesis; inflatable (self-contained)  (Global: 090)
    └── 54405   Insertion of multi-component, inflatable penile prosthesis  (Global: 090)

---

💰 RVU & Reimbursement Profile

Component	Value
Work RVU (wRVU)	1.30 (verify against current CMS MPFS for applicable year)
Global Period	000 (same day)
Bilateral Indicator	0 — Not applicable; penis is an unpaired midline structure; bilateral reduction rules do not apply
Assistant Surgeon	❌ Not payable
Co-Surgeon	❌ Not applicable
Team Surgery	❌ Not applicable
PC/TC Split	❌ No — procedure code only (Indicator 0)
Modifier -51 Exempt	No
Anesthesia	Local or topical anesthesia at injection site; no separate anesthesia billing expected for routine ICI; general or regional anesthesia is not standard for this procedure

Medicare Frequency Limitation — Critical Revenue Cycle Awareness

Unlike most CPT codes whose billing frequency is limited only by medical necessity documentation, CPT 54235 is subject to explicit frequency restrictions under many Medicare contractor and commercial payer policies. Some MACs have historically allowed only one lifetime billing per Medicare beneficiary for the diagnostic/titration injection; others allow a limited number of annual encounters. The AAPC My Urology Coding Alert notes: “Several Medicare carriers have limited the benefit to once per beneficiary lifetime.” Before billing 54235 for a repeat encounter — particularly for a Medicare patient — query the applicable MAC’s LCD or coverage article and the commercial payer’s coverage policy. Billing 54235 repeatedly without verifying frequency policy creates denial and recoupment risk.

---

🏷️ Modifier Reference

Modifier	Name	When to Apply
-25	Significant, Separately Identifiable E/M	Applied to the E/M code — not 54235 — when an office visit is performed on the same date and documentation supports a separately identifiable medical evaluation beyond the pre-procedure assessment; the 000-day global means only same-day E/M bundling is at issue; ensure E/M note addresses a distinct clinical decision separate from routine ICI management
-59	Distinct Procedural Service	When 54235 is reported alongside 93980 or 93981 (penile duplex Doppler ultrasound) on the same date; documents that the injection and the imaging study are distinct services performed for a unified diagnostic purpose but representing separate work; apply -59 to the lower-valued code to overcome potential same-day bundling edits
-52	Reduced Services	When the procedure is initiated but the full injection is not completed (e.g., patient intolerance, vasovagal response, needle malpositioning); document the reason for incomplete service
-76	Repeat Procedure by Same Physician	When 54235 is performed a second time on the same date by the same physician (e.g., insufficient initial dose response requiring a repeat injection in the same visit for dose titration); document medical necessity for the repeat injection
-79	Unrelated Procedure During Postoperative Period	Not applicable — 000-day global period means no postoperative window; no modifier required for services on subsequent dates

---

🩺 Common ICD-10-CM Pairings

Organic Erectile Dysfunction — Vasculogenic

ICD-10 Code	Description	HCC?	Clinical Notes
N52.01	Erectile dysfunction due to arterial insufficiency	❌ No	Document arterial etiology (e.g., atherosclerosis, hypertension-related); supports medical necessity for ICI as second-line therapy when PDE5 inhibitors have failed
N52.02	Corporo-venous occlusive erectile dysfunction	❌ No	Venous leak etiology; identified on penile duplex Doppler; supports diagnostic ICI + 93980 combined encounter
N52.03	Combined arterial insufficiency and corporo-venous occlusive erectile dysfunction	❌ No	Most common vascular pattern; document both components when present; supports combined 54235 + 93980 diagnostic study

Post-Procedural Erectile Dysfunction

ICD-10 Code	Description	HCC?	Clinical Notes
N52.31	Erectile dysfunction following radical prostatectomy	❌ No	Most common post-surgical ED indication for ICI; document prior prostatectomy; common in urology and PMR post-surgical rehabilitation
N52.32	Erectile dysfunction following radical cystectomy	❌ No	Post-51597 pelvic exenteration or radical cystectomy setting; pair with history of bladder malignancy as secondary
N52.33	Erectile dysfunction following urethral surgery	❌ No	Post-urethroplasty ED; document surgical history
N52.35	Erectile dysfunction following radiation therapy	❌ No	Post-external beam or brachytherapy ED; common in prostate cancer survivors; document radiation type if available
N52.9	Male erectile dysfunction, unspecified	❌ No	Use only when etiology is not documented or determinable; query provider for etiology specificity before defaulting to unspecified

Priapism (Sympathomimetic Injection Indication)

ICD-10 Code	Description	HCC?	Clinical Notes
N48.31	Priapism due to trauma	❌ No	Traumatic arterial priapism (non-ischemic); less common indication for injection therapy; sympathomimetic injection less effective for non-ischemic type
N48.32	Priapism due to disease classified elsewhere	❌ No	Includes sickle cell disease-related priapism (D57.x as etiology); code the underlying disease as secondary
N48.39	Other priapism	❌ No	Drug-induced priapism (e.g., trazodone, antipsychotics, prior ICI overdose); document the causative agent if known; ICD-10-CM adverse effect coding may apply

Neurogenic and Other Erectile Dysfunction

ICD-10 Code	Description	HCC?	Clinical Notes
N52.1	Erectile dysfunction due to diseases classified elsewhere	❌ No	Neurogenic ED from multiple sclerosis, spinal cord injury, diabetes; code the underlying condition (e.g., G35.D, M54.3, E11.9) as secondary
F52.21	Male erectile disorder (psychogenic)	❌ No	Rare indication for ICI; document that organic causes have been excluded; psychogenic ED is better treated with other modalities; rarely appropriate for ICI billing

Coding Specificity Reminder

The ICD-10-CM N52 family for erectile dysfunction has 12 distinct codes organized by etiology and surgical cause. The single most common specificity gap is defaulting to N52.9 (unspecified) when a surgically specific code is available. For any patient with known prior prostatectomy, cystectomy, radiation, or urethral surgery, the procedure-specific N52.3x subcode is always available and always preferred over N52.9. Query the urologist for etiology documentation when only “erectile dysfunction” appears in the medical record. ICD-10-CM specificity requirements are not optional.

---

🏥 MS-DRG Considerations (Inpatient)

Inpatient Coding Reminder

CPT 54235 is performed primarily in the outpatient and office setting. Inpatient admission for routine ICI therapy is not clinically expected and would not be supported by payer utilization review. When this procedure is performed during an inpatient stay — most commonly for treatment of ischemic priapism in the emergency setting, or as part of post-surgical erectile rehabilitation in an admitted patient — the ICD-10-PCS code 3E0N3GC is assigned on the facility claim. This PCS code is a non-OR procedure and does not independently drive DRG assignment. The inpatient DRG is determined by the principal diagnosis:

• Erectile dysfunction (N52.x) as PDx → MDC 12, DRG 729 (Other Male Reproductive System Diagnoses with CC/MCC) or DRG 730 (without CC/MCC)
• Priapism (N48.3x) as PDx → MDC 12, same DRG family 729/730

CC/MCC documentation is important even for this lower-acuity DRG family: hypertension, diabetes, sickle cell disease, or sepsis coded as secondary diagnoses may influence DRG tiering when present and documented.

---

🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)

Note

CPT 54235 maps to the Administration section (3) of ICD-10-PCS — specifically the Introduction root operation — because it involves putting a pharmacologic substance into a body region without a Medical and Surgical operative intent. The relevant body system/region value is Male Reproductive (N). This is a non-OR procedure in ICD-10-PCS, meaning it does not independently affect DRG assignment. A single PCS code captures the full injection regardless of the number of agents injected (trimix is still one code) or the number of injection attempts.

PCS Code	Full Description	Applicable Use
3E0N3GC	Introduction of Other Therapeutic Substance into Male Reproductive, Percutaneous Approach	Standard code for all ICI — vasoactive agents (papaverine, phentolamine, alprostadil, trimix, bimix) injected into the corpora cavernosa for ED treatment or diagnostic purposes
3E0N33Z	Introduction of Anti-inflammatory into Male Reproductive, Percutaneous Approach	When a corticosteroid or anti-inflammatory is injected into the corpora (rare; more applicable to Peyronie’s plaque injection; verify clinical intent before using)

PCS Character Analysis — 3E0N3GC

Position	Character	Value	Definition
1	Section	3	Administration
2	Physiological System / Anatomical Region	E	Physiological Systems and Anatomical Regions
3	Root Operation	0	Introduction (putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products)
4	Body System / Region	N	Male Reproductive
5	Approach	3	Percutaneous
6	Substance	G	Other Therapeutic Substance
7	Qualifier	C	Other Substance

PCS Administration Section — Not Medical and Surgical

Unlike most urology PCS codes in the Medical and Surgical section (Section 0), CPT 54235 maps to the Administration section (Section 3). This distinction matters because Administration codes are fundamentally different in structure and purpose: they capture the act of introducing a substance, not cutting, altering, or repairing tissue. The single code 3E0N3GC captures all vasoactive agent ICI regardless of the specific drug, combination, or number of injections performed. There is no separate PCS code for trimix vs. bimix vs. alprostadil monotherapy — the Substance character (G = Other Therapeutic Substance) and Qualifier (C = Other Substance) cover all of these vasoactive agents.

---

📝 Coding Examples

---

Example 1 — Office: Diagnostic ICI with Penile Duplex Doppler Ultrasound

Clinical Scenario: A 58-year-old male with a 2-year history of erectile dysfunction refractory to sildenafil and tadalafil presents to the urology office for diagnostic evaluation. The urologist injects 20 mcg of alprostadil (supplied by the practice) into the right lateral corpus cavernosum. After 10 minutes, a penile duplex Doppler ultrasound is performed at the 5-minute, 10-minute, and 20-minute marks post-injection to characterize arterial peak systolic velocity and venous end-diastolic velocity, identifying combined arterial insufficiency and venous leak. The urologist documents a separate clinical evaluation of the patient’s cardiovascular history and medication review during the same encounter, distinct from the procedure assessment.

Field	Code	Rationale
CPT 1	54235	Intracavernosal injection of alprostadil into the corpora cavernosa
CPT 2	93980-59	Penile duplex Doppler ultrasound, complete study — distinct service performed for vascular characterization; -59 documents separate service from the injection
Drug	J0270 × 20 units	Alprostadil injection, per 1 mcg — 20 mcg supplied by the practice; separately billable per AMA CPT Assistant guidance
E/M	99213-25	Office visit — modifier -25 on the E/M code; documentation supports a separately identifiable evaluation of cardiovascular comorbidities and medication reconciliation
PDx	N52.03	Combined arterial insufficiency and corporo-venous occlusive erectile dysfunction — confirmed by duplex results

Note

Modifier -25 is appended to the E/M code — NOT to 54235. The 000-day global period means only the same-day E/M is at issue; any E/M on a subsequent date requires no modifier. Confirm that the E/M note documents clinical content distinct from the routine pre-procedure assessment of the ICI itself to defend the -25 on audit.

---

Example 2 — Office: Therapeutic ICI Titration Visit, Post-Prostatectomy ED

Clinical Scenario: A 65-year-old male with erectile dysfunction following robotic-assisted radical prostatectomy 8 months prior presents for his second ICI titration visit. His initial dose of trimix (compounded by an outside pharmacy — patient-supplied) was inadequate. The urologist performs a second injection with an increased dose of trimix prepared from a practice-supplied vial to confirm the therapeutic response before the patient transitions to self-injection therapy at home. The urologist documents the injection, the erection quality score, and duration of response. No separate E/M visit is documented for this encounter.

Field	Code	Rationale
CPT	54235	ICI, repeat titration visit — provider performs the injection; each provider-performed injection encounter is billable; patient self-injections at home are NOT separately billable
Drug	J3490	Trimix (compounded vasoactive agent), NOC drug — billable when practice supplies the drug; J3490 (drug, not otherwise classified) or J3590 applies to compounded trimix per payer policy
PDx	N52.31	Erectile dysfunction following radical prostatectomy — most specific available code; do not default to N52.9

Warning

Frequency limitation alert: Before billing this second encounter with 54235, verify Medicare MAC or commercial payer frequency policy for this code. Some MACs allow only one lifetime encounter; others have annual or per-course limits. If the payer’s policy restricts repeat billing of 54235, the therapeutic injection at a follow-up titration visit may need to be captured as part of the E/M service rather than billed as a separate procedure code. Document the clinical rationale (inadequate initial dose response) in the medical record regardless.

---

Example 3 — Emergency Department / Office: Ischemic Priapism, Sympathomimetic Injection

Clinical Scenario: A 34-year-old male with sickle cell disease (D57.1) presents to the urology clinic with a 5-hour painful erection. After assessment confirming ischemic priapism by blood gas analysis, the urologist performs corporal aspiration and irrigation (54220) followed by injection of diluted phenylephrine (1 mg in 19 mL normal saline, 1 mL aliquots) into each corpus cavernosum until detumescence is achieved. The patient’s erection resolves after three phenylephrine aliquots. The practice supplies the phenylephrine.

Field	Code	Rationale
CPT 1	54220	Corporal aspiration and irrigation for priapism — primary procedural step
CPT 2	54235-59	Intracavernosal injection of phenylephrine (sympathomimetic) — distinct from irrigation; -59 documents separate injection service; note: many payers will only reimburse one code — verify before billing both
Drug	J3490	Phenylephrine injection, NOC drug — practice-supplied; billable in addition to 54235 per AMA guidance
PDx	N48.32	Priapism due to disease classified elsewhere — sickle cell disease is the underlying disease
SDx	D57.1	Sickle cell disease without crisis — underlying etiology driving the priapism episode

Note

Global period reminder: CPT 54235 has a 000-day global period. The global package applies only on the date of service — routine follow-up on the next day or any subsequent date does not require a modifier and is not bundled. When both 54220 and 54235 are reported for the same priapism treatment session, many commercial payers will only reimburse 54220 and deny 54235 as bundled, despite the absence of an NCCI edit between these codes. Append modifier -59 to 54235 and ensure the procedure note documents the aspiration/irrigation and the injection as separately performed services.

---

⚠️ Common Coding Pitfalls

• Billing 54235 for patient self-injections performed at home: The code descriptor and clinical intent of 54235 require that the physician performs the injection during an office encounter. When a trained patient self-injects at home following ICI training, no CPT code is reportable by the practice — the home injection is not a billable service. Billing 54235 for patient-reported self-injection encounters that did not involve a provider-performed injection constitutes false claims. The in-office training encounter (where the provider demonstrates technique and the patient performs the first injection under supervision) is a billing gray area — the provider must have administered or directly supervised the injection for 54235 to be billable.

• Failing to separately bill the drug supply when the practice provides the agent: CPT 54235 covers only the injection procedure itself — the pharmacologic agent is NOT included per AMA CPT Assistant. When the practice supplies alprostadil, trimix, bimix, or phenylephrine, the drug must be separately billed using the appropriate HCPCS J-code (J0270 for alprostadil, J3490/J3590 for compounded agents). Failing to separately bill the drug when practice-supplied results in significant uncaptured revenue in high-volume ICI urology practices.

• Billing 54235 for lidocaine local anesthetic injection before another penile procedure: 54235 is specifically for pharmacologic agents injected into the corpora cavernosa — the erectile tissue itself. Subcutaneous lidocaine injection for local anesthesia prior to performing 54200 (Peyronie’s injection) or other penile procedures does NOT meet the descriptor of 54235, which requires injection into the corporal body. Billing 54235 for anesthetic infiltration creates an incorrect code assignment and potential overpayment liability.

• Not verifying Medicare frequency policy before billing repeat encounters: Several Medicare MACs have historically restricted 54235 to once per beneficiary lifetime or have specific annual frequency limits. Billing multiple encounters without verifying the applicable MAC’s or payer’s coverage and frequency policy creates denial and recoupment risk. Always check the applicable LCD or coverage article for the specific MAC before submitting repeat 54235 claims, particularly for Medicare patients.

• Defaulting to N52.9 (unspecified erectile dysfunction) without querying for etiology: The ICD-10-CM N52 family has 12 etiology-specific codes. In urology practice — especially post-prostatectomy and post-radiation patients — the etiology of erectile dysfunction is almost always known and documented. Using N52.9 when a more specific code (e.g., N52.31 for post-prostatectomy, N52.35 for post-radiation) is available represents a coding specificity failure and potentially misrepresents the patient’s clinical picture. Always cross-reference the procedure note, history, and diagnosis list before assigning N52.9.

• Confusing 54235 with 54200 (Peyronie’s injection) or 54240 (penile plethysmography): 54200 is for injection into the Peyronie’s plaque for disease treatment (collagenase, steroids, interferon), not into the corpora cavernosa for ED or priapism. 54240 (penile plethysmography) is a diagnostic measurement code — entirely distinct. These codes are in the same CPT subsection and are occasionally miscoded by non-specialist coders. Confirm the anatomic target (plaque vs. corpus) and procedural intent (disease treatment vs. pharmacologic erection) before code selection.

---

📎 Sources

¹ AMA CPT 2025 Professional Edition — CPT 54235, Surgery: Male Genital System, Introduction Procedures on the Penis · ² AMA CPT Assistant, September 1996, p. 10d — “Male Genital System, 54150, 54161, 54235 (Q&A)”: drug supply is NOT included in CPT 54235; separately report drug supply with additional code · ³ CMS 2025 Medicare Physician Fee Schedule Final Rule (CMS-1807-F); CMS RVU25A Relative Value Files — CPT 54235 wRVU 1.30, Global Period 000 · ⁴ NCCI Policy Manual Chapter 7 (Urinary System / Male Genital System), CMS 2025 — bundling relationship between 54220 and 54235 · ⁵ ICD-10-CM Official Guidelines for Coding and Reporting FY2025 — Section I.C.14 (Diseases of the Genitourinary System; erectile dysfunction etiology specificity) · ⁶ ICD-10-PCS Official Guidelines for Coding and Reporting FY2025 — Administration Section (Section 3), Root Operation Introduction · ⁷ CMS ICD-10 MS-DRG v42.1 Definitions Manual — MDC 12, DRG 729/730 (Other Male Reproductive System Diagnoses) · ⁸ AAPC My Urology Coding Alert — “Check with Your Payer First: Billing for 54235” — Medicare frequency limitations discussion · ⁹ Prebay ZJ et al. “Evaluating the management trends for priapism and assessing the risk of priapism after in-office intracavernosal injections.” Int J Impot Res 37:465-470 (2025). doi:10.1038/s41443-024-00861-2 · ¹⁰ Medic Management — “Billing CPT 51720 with Bladder Tumor Resections” (2023) — same-day injection bundling context applicable to 54235 + 51720 same-session scenarios